Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CurifyLabs logo — Automated compounding of personalized medicine

CurifyLabs

Automated compounding of personalized medicine

Founded 2021 Finland Finland 33 employees Series A Total: $24.31M Biotechnology, Health Care +2

General Information

Company Name CurifyLabs
Founded Year 2021
Location Finland Finland +3
Employees 33
Industries Biotechnology, Health Care, Pharmaceutical +1
Funding Stage Series A
Social

Get notified when CurifyLabs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CurifyLabs

CurifyLabs, established in 2021 in Finland, is a pioneering healthtech startup specializing in the automated compounding of personalized medicine. Operating in the intersections of Biotechnology, Health Care, Pharmaceutical, and 3D Printing industries, the company is transforming how personalized medicines are produced in pharmacies and hospitals.

The company’s flagship innovation, the Compounding System Solution (CSS), offers a sophisticated yet user-friendly platform that automates the traditionally manual and time-intensive process of pharmaceutical compounding. The CSS supports non-sterile dosage forms, ensuring precise, in-process quality control, thus enabling better patient care and operational efficiencies for healthcare providers across Europe and the US.

In May 2025, CurifyLabs secured a €6.70M Debt Financing investment from Springvest Oyj, underscoring investor confidence in its innovative solutions and growth potential in personalized medicine manufacturing.

Taxonomy: Healthtech, Personalized Medicine, Pharmaceutical Compounding, Automated Manufacturing, 3D Printing in Pharmaceuticals, Non-Sterile Dosage Forms, Pharmacy Automation, Hospital Pharmacy Solutions, Compounding Robotics, In-Process Quality Control, GMP Standards, Formulation Library, Cost Efficiency, Patient Safety, Mass Customization of Medicines

Services & Products

Automated Compounding Systems
Compounding Software Platform
Robotics for Pharmacy
Personalized Dosage Forms
Excipient Bases Production

Target Customers

Pharmacists Hospital Pharmacies Compounding Retail Pharmacies Pediatric Cancer Treatment Centers Healthcare Providers for Underserved Populations

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• •••• 		06 Jul 2026
Debt Financing •••••• 1
Investor
01 May 2025
Grant •••••• 1
Investor
01 Jan 2023
Seed •••••• 1
Investor
01 Apr 2022
Seed •••••• 2
Investor Investor
01 Nov 2021

View All 6 Funding Rounds

Latest News

View All
CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience — Tech
CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience
Tech May 27, 2025
Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalis... — Eu-startups
Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalised
Eu-startups May 27, 2025
As millions await approved therapies, myTomorrows strengthens its global patient-access mission with... — Eu-startups
As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million
Eu-startups Nov 11, 2025
CurifyLabs bags €12M to automate personalised medicine — Tech
CurifyLabs bags €12M to automate personalised medicine
Tech Jul 06, 2026
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding — Eu-startups
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding
Eu-startups Jul 06, 2026
Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US — Thenextweb
Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US
Thenextweb Jul 06, 2026

CurifyLabs Alternatives & Competitors

View All Alternatives
CurifyLabs vs
Doser
Doser The Netherlands

3D Compounding For Personalized Care

8 employees
Health Care, Pharmaceutical
Compare CurifyLabs vs Doser
CurifyLabs vs
Wells Pharmacy Network
Wells Pharmacy Network United States

Compounding Pharmacy. Wellness, anti-aging, sexual health & vet. CALL: 800-622-4510 | WEB: orders.w...

140 employees
Health Care, Pharmaceutical
Compare CurifyLabs vs Wells Pharmacy Network
CurifyLabs vs
Healistic
Healistic United Kingdom

Healistic empowers doctors to securely issue private e-prescriptions in seconds. Patients receive me...

Seed
14 employees
E-Commerce, Health Care
Compare CurifyLabs vs Healistic
View all alternatives

FAQ About CurifyLabs

Automated compounding of personalized medicine
CurifyLabs was founded in 2021.
CurifyLabs is headquartered in Finland.
CurifyLabs operates in the following industries: Biotechnology, Health Care, Pharmaceutical, 3D Printing.
CurifyLabs has approximately 33 employees.
CurifyLabs has completed 6 funding rounds, raising a total of $24.31M. The latest funding stage is Series A.
CurifyLabs offers: Automated Compounding Systems, Compounding Software Platform, Robotics for Pharmacy, Personalized Dosage Forms, Excipient Bases Production.
Top alternatives and competitors to CurifyLabs include Doser, Wells Pharmacy Network, Healistic, Plasmics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CurifyLabs and Doser are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CurifyLabs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy